Oruka Therapeutics (ORKA) to Release Earnings on Thursday

Oruka Therapeutics (NASDAQ:ORKA) will likely be posting its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Oruka Therapeutics to post earnings of ($0.68) per share for the quarter.

Oruka Therapeutics Price Performance

Shares of ORKA opened at $13.70 on Tuesday. The company has a market capitalization of $479.50 million, a PE ratio of -2.19 and a beta of 0.77. The stock has a fifty day simple moving average of $18.19. Oruka Therapeutics has a fifty-two week low of $10.95 and a fifty-two week high of $53.88.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Stifel Nicolaus started coverage on Oruka Therapeutics in a research report on Friday, October 11th. They issued a “buy” rating and a $49.00 price target for the company. HC Wainwright reissued a “buy” rating and set a $45.00 target price on shares of Oruka Therapeutics in a research report on Friday, December 20th. Finally, Wedbush restated an “outperform” rating and issued a $40.00 price target on shares of Oruka Therapeutics in a research report on Tuesday, November 19th. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Oruka Therapeutics presently has an average rating of “Buy” and an average price target of $43.17.

Oruka Therapeutics Company Profile

Oruka Therapeutics, Inc is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.